The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

Roche reported flat Q1 sales for its diagnostic division, citing headwinds in China, but reaffirmed the market’s strategic ...

AbbVie is now pushing Skyrizi and Rinvoq to counter the drop in Humira sales and has forecast the two newer drugs to generate ...

Switzerland, as one of 15 countries, is engaged in 'privileged' negotiations with the US to mitigate impacts of new tariffs.

The Swiss president says Switzerland is among 15 countries with which the United States plans to conduct “privileged” negotiations to help reach a deal in the wake of sweeping U.S. tariffs on dozens o ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Roche posted higher sales that beat analysts’ expectations on higher demand for its key drugs.

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo, eye drug Vabysmo and allergy treatment Xolair.

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...